Innovative Cardiac Imaging Arineta's flagship product, SpotLight Duo, is the world’s first dedicated single-heartbeat, whole heart cardiac CT scanner, offering a unique selling point for healthcare providers seeking advanced, efficient cardiac imaging solutions.

FDA Clearance & Market Expansion The recent FDA approval for low-dose lung cancer screening with SpotLight Duo opens opportunities to target U.S. hospitals and clinics looking for cutting-edge, minimally invasive imaging options.

Strategic Partnerships Collaborations with companies like CatalystMedTech and GE Healthcare suggest strong distribution and sales channels in North America, paving the way for accelerated market penetration and bundled offering strategies.

Growing Leadership New executive appointments, including a seasoned CEO, demonstrate Arineta's dedication to expanding its operational expertise and scaling sales efforts in competitive markets.

Increasing Revenue & Funding With revenues estimated between $25 million and $50 million, Arineta is positioned as a profitable innovator, presenting opportunities to collaborate on advanced imaging projects and technology licensing.